Clinical Trial Update: Using IVR to Maintain ACS Patients on Best Practice Guidelines [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating IVR to keep acute coronary syndrome patients on best-practice guidelines was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Acute Coronary Syndrome, Medication Adherence | Phase 3 | Status: TERMINATED